Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3CNS 2Sarcoma 1Other 1Myeloid 1Endocrine 1Dermatologic 1Classical hematology 1

Conditions

Sarcoma 267Osteosarcoma 81Sarcoma, Ewing 51Melanoma 44Neoplasms 43Gastrointestinal Stromal Tumors 41Colorectal Neoplasms 39Breast Neoplasms 38Rhabdomyosarcoma 36Bone Neoplasms 36Ovarian Neoplasms 32Neoplasm Metastasis 32Neuroblastoma 30Pancreatic Neoplasms 29Stomach Neoplasms 28Leiomyosarcoma 27Dendritic Cell Sarcoma, Interdigitating 27Lung Neoplasms 26Liposarcoma 26Glioblastoma 23Uterine Cervical Neoplasms 22Sarcoma, Synovial 22Head and Neck Neoplasms 22Carcinoma, Non-Small-Cell Lung 22Esophageal Neoplasms 21Lymphoma 19Sarcoma, Kaposi 18Prostatic Neoplasms 18Carcinoma, Hepatocellular 18Urinary Bladder Neoplasms 17

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Gaucher Disease × Sarcoma × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡